Cancer Vaccines
New cancer vaccines study findings reported from Cleveland Clinic
Published in Cancer Weekly, August 11th, 2009
"A randomized phase II trial was conducted in 40 patients with PSA progression. had PSA doubling times less than 10 months, with no overt evidence of disease. received either weekly subcutaneous injection (sc) of TG4010 10(8) pfu for 6 weeks, then one injection every 3 weeks or sc injection of TG4010 10(8) pfu every 3 weeks. The primary endpoint of a 50% decrease in PSA values from baseline was not observed....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-08-11)
More Articles from Cancer Weekly
- American Cancer Society
Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer - Ludwig Institute for Cancer Research
Could therapeutic vaccines treat hard to beat breast cancers? - University of Maryland Medical Center
Low prevalence of HPV infection may be tied to poor prognosis for blacks with head and neck cancer - Angiogenesis
PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 - AuthorHouse
'Stepping Over Myself': From Promising Tennis Player to Death's Door - Cancer Gene Therapy
New cancer gene therapy study findings have been published by scientists at Northeastern University - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
